Our comprehensive and fully customizable product offerings support both manual and automated workflows, providing easy to read results in approximately 2.5 hours.

checkmarkFlexible, turnkey COVID testing solutions for low to mid-volume CLIA labs
checkmarkFlexible sample volumes and volume-based discounting
checkmarkEliminate backorders and supply-chain issues
checkmarkPlug and play with existing reagents and equipment

Sample collection

– Nasopharyngeal swabs
– Transport Media

Disposable swabs and inactivated transport media, individually packaged and ready for use.

RNA extraction

The advanced kit is designed for manual testing in small laboratory spaces for low testing volumes. Each kit allows for extraction of 96 samples.

The automated kit is ideal for mid-volume labs with limited personnel. With options to run 32 or 96 samples per batch, our automated extraction instruments fit your testing capacity needs.

Advanced isolation

Reagents & spin columns

Automated isolation

Plates & beads

GeneCount® E-32 auto extraction instrument

32 -sample capacity

GeneCount® E-96 auto extraction instrument

96 -sample capacity

qPCR testing

The Q-16 qPCR Instrument is lightweight and fully portable with the field case provided. Assess up to 16 samples in 2.5 hours from sample collection to result interpretation.

The Q-96 qPCR Instrument has an easy-to-use touch screen interface and can run up to 96 samples.

GeneCount® qPCR assay

  • 96 samples
  • Primer/reagent mix
  • Positive & negative controls

GeneCount® Q-16 qPCR Instrument

16-sample capacity

GeneCount® Q-96 qPCR Instrument

96 -sample capacity

Analysis software

Analyze results, look at trends in your data, and plan out testing and reporting via the GeneCount® software. Access the software as well as helpful video tutorials and trouble-shooting advice via the user-friendly my.luminultra.com portal.


Click here to open lightbox



Contact us about clinical testing solutions

Want more information or a customized quote? Fill out the form below and we’ll get in touch.

Compliance statements

  • The LuminUltra GeneCount® COVID-19 RT-qPCR Assay Kit has completed the Section IV.C notification process under FDA’s “Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)” and has not been reviewed by FDA.
  • Health Canada has granted an Interim Order authorizing all devices included in the submission, to be imported, sold and advertised in Canada, for the duration that the Interim Order is in effect.
  • Additional application pending with the European Union for CE IVD.
  • All tests must be conducted in accordance with the local laws and regulations.
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now